Literature DB >> 5636990

Release of noradrenaline from the cat spleen by potassium.

S M Kirpekar, A R Wakade.   

Abstract

1. Cat spleens were perfused with Krebs-bicarbonate solution by means of a constant flow pump. The amount of noradrenaline released by an injection of potassium chloride solution (3.7M) was measured. The dependence of noradrenaline released by KCl on the ionic composition of perfusion medium was determined.2. In normal cats, the average output was 166 ng following a low dose of KCl (0.2 ml.), and 507 ng following a high dose (0.8 ml.). After phenoxybenzamine treatment, the outputs with both doses were nearly doubled.3. In both normal and phenoxybenzamine treated cats, removal of calcium from the perfusing solution nearly abolished the release of noradrenaline. Replacing the calcium in Krebs solution restored the output. Increasing the magnesium concentration to 20 mM also markedly reduced the noradrenaline output.4. Lowering the sodium concentration to either 25 or 0 mM increased the noradrenaline output by nearly two- to threefold. In solutions with reduced concentrations of sodium, noradrenaline was released over longer periods following KCl injections. In phenoxybenzamine treated cats, reduction of sodium in the perfusing solution also increased the noradrenaline output by nearly twofold following either the low or the high dose of KCl.5. It is concluded that calcium ions are necessary for the release of noradrenaline from post-ganglionic sympathetic nerves following depolarization by potassium ions. It is also suggested that sodium ions are specifically needed for the reincorporation of released transmitter into the sympathetic nerve endings.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5636990      PMCID: PMC1365655          DOI: 10.1113/jphysiol.1968.sp008427

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  ACTIONS AND INTERACTIONS OF NOREPINEPHRINE, TYRAMINE AND COCAINE ON AORTIC STRIPS OF RABBIT AND LEFT ATRIA OF GUINEA PIG AND CAT.

Authors:  R F FURCHGOTT; S M KIRPEKAR; M RIEKER; A SCHWAB
Journal:  J Pharmacol Exp Ther       Date:  1963-10       Impact factor: 4.030

3.  THE INACTIVATION OF INFUSED NORADRENALINE BY THE CAT SPLEEN.

Authors:  J S GILLESPIE; S M KIRPEKAR
Journal:  J Physiol       Date:  1965-01       Impact factor: 5.182

4.  The role of calcium in the secretory response of the adrenal medulla to acetylcholine.

Authors:  W W DOUGLAS; R P RUBIN
Journal:  J Physiol       Date:  1961-11       Impact factor: 5.182

5.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

6.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

7.  The effect of magnesium on the activity of motor nerve endings.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

8.  The action of calcium on neuronal synapses in the squid.

Authors:  R Miledi; C R Slater
Journal:  J Physiol       Date:  1966-05       Impact factor: 5.182

9.  Factors influencing noradrenaline uptake by the perfused spleen of the cat.

Authors:  S M Kirpekar; A R Wakade
Journal:  J Physiol       Date:  1968-02       Impact factor: 5.182

10.  Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.

Authors:  S M Kirpekar; Y Misu
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

View more
  36 in total

1.  Proceedings: Mechanism of K+-induced release of cytoplasmic noradrenaline from adrenergic nerves.

Authors:  D M Paton
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Inhibition of adrenergic neurotransmission in isolated veins of the dog by potassium ions.

Authors:  R R Lorenz; P M Vanhoutte
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

3.  Influence of cocaine and sodium on bretylium uptake by reserpine-treated guinea-pig left atrium.

Authors:  A G García; P Sánchez-García
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

4.  Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.

Authors:  J M Allen; J G McCarron; N G McHale; K D Thornbury
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Effect of butyrophenones on the sympathetic nerves of the isolated rabbit heart and on the postsynaptic alpha-adrenoceptors of the isolated rabbit aorta.

Authors:  M Göthert; H J Lox; J M Rieckesmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

6.  Release of noradrenaline from cat spleen slices by potassium.

Authors:  A G Garcia; S M Kirpekar; R Pascual
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

7.  Mechanism of nicotine-induced release of noradrenaline from adrenergic nerve endings.

Authors:  S Jayasundar; M M Vohra
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

8.  Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro.

Authors:  M P Blaustein; E M Johnson; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

9.  Release of noradrenaline from the cat spleen by nerve stimulation and potassium.

Authors:  A G Garcia; S M Kirpekar; P Sanchez-Garcia
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

10.  Histamine release by exocytosis from rat mast cells on reduction of extracellular sodium: a secretory response inhibited by calcium, strontium, barium or magnesium.

Authors:  D E Cochrane; W W Douglas
Journal:  J Physiol       Date:  1976-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.